These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23452775)

  • 1. [The national plan for orphan rare diseases: nearly 10 years on].
    Guillevin L
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S9-11. PubMed ID: 23452775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Orphanet and its consortium: where to find expert-validated information on rare diseases].
    Maiella S; Rath A; Angin C; Mousson F; Kremp O
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S3-8. PubMed ID: 23452769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Orphanet: a European database for rare diseases].
    Weinreich SS; Mangon R; Sikkens JJ; Teeuw ME; Cornel MC
    Ned Tijdschr Geneeskd; 2008 Mar; 152(9):518-9. PubMed ID: 18389888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Orphanet and the Dutch Steering Committee Orphan Drugs. A European and Dutch databank of information on rare diseases].
    Liem SL
    Ned Tijdschr Tandheelkd; 2008 Nov; 115(11):621-3. PubMed ID: 19058507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare neurological diseases: a Pandora's box for neurology (an European and Italian perspective).
    Federico A
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S12-7. PubMed ID: 23452765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Documentary research and self-instruction. Critical reading of a medical article. Practice guidelines. Part 1: rare diseases].
    Cordier JF; Aymé S
    Rev Prat; 2004 Apr; 54(7):777-9. PubMed ID: 15253297
    [No Abstract]   [Full Text] [Related]  

  • 7. Polish activity within Orphanet Europe--state of art of database and services.
    Jezela-Stanek A; Karczmarewicz D; Chrzanowska KH; Krajewska-Walasek M
    Dev Period Med; 2015; 19(4):536-41. PubMed ID: 26982769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Orphanet, an information site on rare diseases].
    Aymé S
    Soins; 2003; (672):46-7. PubMed ID: 12655825
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current views on rare diseases research and orphan drugs development].
    Jiang J; Li J; Liu W
    Sheng Wu Gong Cheng Xue Bao; 2011 May; 27(5):724-9. PubMed ID: 21845839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Orphan Drug Act and the development of stem cell-based products for rare diseases.
    Freeman SN; Burke KA; Imoisili MA; Coté TR
    Cell Stem Cell; 2010 Sep; 7(3):283-7. PubMed ID: 20804965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEMARA: a Web dynamic application within a N-tier architecture for rare diseases.
    Messiaen C; Le Mignot L; Rath A; Richard JB; Dufour E; Ben Said M; Jais JP; Verloes A; Le Merrer M; Bodemer C; Baujat G; Gerard-Blanluet M; Bourdon-Lanoy E; Salomon R; Ayme S; Landais P
    Stud Health Technol Inform; 2008; 136():51-6. PubMed ID: 18487707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rare Diseases: Joining Mainstream Research and Treatment Based on Reliable Epidemiological Data.
    Groft SC; Posada de la Paz M
    Adv Exp Med Biol; 2017; 1031():3-21. PubMed ID: 29214563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Call for a national plan for rare diseases.
    Jaffe A; Zurynski Y; Beville L; Elliott E
    J Paediatr Child Health; 2010 Jan; 46(1-2):2-4. PubMed ID: 19943870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are internet service providers responsible for online suicide pacts?
    Cheng Q
    BMJ; 2011 Apr; 344():d2113. PubMed ID: 22505035
    [No Abstract]   [Full Text] [Related]  

  • 15. National Organization for Rare Disorders (NORD): providing advocacy for people with rare disorders.
    Putkowski S
    NASN Sch Nurse; 2010 Jan; 25(1):38-41. PubMed ID: 20440954
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role and actions of the orphan rare diseases reference center for central hypersomnias in France].
    Vecchierini MF; Léger D; Arnufl I; Dauvilliers Y
    Rev Neurol (Paris); 2013 Feb; 169 Suppl 1():S56-62. PubMed ID: 23452773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drugs for rare diseases: mixed assessment in Europe.
    Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rare diseases: what's next?
    Remuzzi G; Garattini S
    Lancet; 2008 Jun; 371(9629):1978-9. PubMed ID: 18555899
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rare diseases, definitions and epidemiology].
    Donnart A; Viollet V; Roinet-Tournay M
    Soins Pediatr Pueric; 2013; (274):14-6. PubMed ID: 24228328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What the Orphan Drug Act has done lately for children with rare diseases: a 10-year analysis.
    Thorat C; Xu K; Freeman SN; Bonnel RA; Joseph F; Phillips MI; Imoisili MA
    Pediatrics; 2012 Mar; 129(3):516-21. PubMed ID: 22371464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.